X-Therma's $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation
/PRNewswire/ -- X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, has completed an...
United States Xiaoxi Wei Jim Greenwood Drug Administration Biotechnology Innovation Organization Sourcex Therma Inc
Source: prnewswire.com